These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16737984)

  • 1. Inhaled fluticasone propionate and adrenal effects in adult asthma: systematic review and meta-analysis.
    Masoli M; Weatherall M; Holt S; Shirtcliffe P; Beasley R
    Eur Respir J; 2006 Nov; 28(5):960-7. PubMed ID: 16737984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review of the dose-response relation of inhaled fluticasone propionate.
    Masoli M; Weatherall M; Holt S; Beasley R
    Arch Dis Child; 2004 Oct; 89(10):902-7. PubMed ID: 15383431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenal responses to low dose synthetic ACTH (Synacthen) in children receiving high dose inhaled fluticasone.
    Paton J; Jardine E; McNeill E; Beaton S; Galloway P; Young D; Donaldson M
    Arch Dis Child; 2006 Oct; 91(10):808-13. PubMed ID: 16556614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenal suppression from high-dose inhaled fluticasone propionate in children with asthma.
    Mohn A; Verini M; Mele R; De Leonardis C; Chiarelli F
    Eur Respir J; 2004 Feb; 23(2):354-5. PubMed ID: 14979518
    [No Abstract]   [Full Text] [Related]  

  • 5. Dose-response relation of inhaled fluticasone propionate in adolescents and adults with asthma: meta-analysis.
    Holt S; Suder A; Weatherall M; Cheng S; Shirtcliffe P; Beasley R
    BMJ; 2001 Aug; 323(7307):253-6. PubMed ID: 11485952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Side-effects of fluticasone in asthmatic children: no effects after dose reduction.
    Visser MJ; van der Veer E; Postma DS; Arends LR; de Vries TW; Brand PL; Duiverman EJ
    Eur Respir J; 2004 Sep; 24(3):420-5. PubMed ID: 15358701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
    Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
    Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled fluticasone propionate: a review of its therapeutic efficacy at dosages < or = 500 microg/day in adults and adolescents with mild to moderate asthma.
    Jarvis B; Faulds D
    Drugs; 1999 May; 57(5):769-803. PubMed ID: 10353302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fluticasone propionate in children and infants with asthma].
    Marchac V; Foussier V; Devillier P; Le Bourgeois M; Polak M
    Arch Pediatr; 2007 Apr; 14(4):376-87. PubMed ID: 17289359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma.
    Markham A; Jarvis B
    Drugs; 2000 Nov; 60(5):1207-33. PubMed ID: 11129128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Airway and systemic effects of hydrofluoroalkane formulations of high-dose ciclesonide and fluticasone in moderate persistent asthma.
    Lee DK; Fardon TC; Bates CE; Haggart K; McFarlane LC; Lipworth BJ
    Chest; 2005 Mar; 127(3):851-60. PubMed ID: 15764767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical dose-response relationship of fluticasone propionate in adults with asthma.
    Masoli M; Weatherall M; Holt S; Beasley R
    Thorax; 2004 Jan; 59(1):16-20. PubMed ID: 14694240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: a systematic review.
    Dyer MJ; Halpin DM; Stein K
    BMC Fam Pract; 2006 Jun; 7():34. PubMed ID: 16753053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
    FitzGerald JM; Boulet LP; Follows RM
    Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined salmeterol 50 microg and fluticasone propionate 250 microg in the diskus device for the treatment of asthma.
    Shapiro G; Lumry W; Wolfe J; Given J; White MV; Woodring A; Baitinger L; House K; Prillaman B; Shah T
    Am J Respir Crit Care Med; 2000 Feb; 161(2 Pt 1):527-34. PubMed ID: 10673196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute adrenal crisis in asthmatics treated with high-dose fluticasone propionate.
    Todd GR; Acerini CL; Buck JJ; Murphy NP; Ross-Russell R; Warner JT; McCance DR
    Eur Respir J; 2002 Jun; 19(6):1207-9. PubMed ID: 12108877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
    Pearlman DS; Stricker W; Weinstein S; Gross G; Chervinsky P; Woodring A; Prillaman B; Shah T
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic ratio of inhaled corticosteroids in adult asthma. A dose-range comparison between fluticasone propionate and budesonide, measuring their effect on bronchial hyperresponsiveness and adrenal cortex function.
    Nielsen LP; Dahl R
    Am J Respir Crit Care Med; 2000 Dec; 162(6):2053-7. PubMed ID: 11112113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of twice-daily inhaled ciclesonide and fluticasone propionate in patients with moderate-to-severe persistent asthma.
    Bateman ED; Linnhof AE; Homik L; Freudensprung U; Smau L; Engelstätter R
    Pulm Pharmacol Ther; 2008; 21(2):264-75. PubMed ID: 17604664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
    Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.